First-line eradication of H pylori infection in Europe: A meta-analysis based on congress abstracts, 1997-2004

World Journal of Gastroenterology

Volumn 12, Issue 33, 2006, Pages 5311-5319

  Bruzás, György M ^a   Józan, Jolán ^b  

^a Ferencvaros Health Center Budapest   (Hungary)

^b Orszagos Traumatologiai Intezet   (Hungary)

Author keywords

Antimicroblasls; Eradication; H pylori; Proton pump inhibitors; Ranitidine bismuth citrate

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; EUROPEAN UNION; GASTROENTEROLOGY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; NONHUMAN; PROSPECTIVE STUDY; PUBLISHING; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOMIZATION; SCORING SYSTEM; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; WORKSHOP;

EID: 33749409144     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i33.5311     Document Type: Article

References (99)

1. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection-a meta-analysis. Aliment Pharmacol Ther 1999; 13: 857-864
2. Houben MH, van de Beek D, Hensen EF, Craen AJ, Rauws EA, Tytgat GN. A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999; 13: 1047-1055
3. Fischbach LA, van Zanten S, Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004; 20: 1071-1082
4. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12
5. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group. Br J Surg 2000; 87: 2558-2564
6. Timmer A, Sutherland LR, Hilsden RJ. Development and evaluation of a quality score for abstracts. BMC Med Res Methodol 2003; 3: 2
7. Malfertheiner P, Megraud F, O'Morain C, Bell D, Bianchi Porro G, Deltenre M, Forman D, Gasbarrini G, Jaup B, Misiewicz JJ, Pajares J, Quina. M, Rauws E. Current European concepts in the management of Helicobacter pylori infection-the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997; 9: 1-2
8. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
9. Rosner B. Fundamentals of Biostatistics. Pacific Grove: Duxbury, 2001: 584-605
10. Knapp R, Clinton Miller III M. Clinical epidemiology and biostatistics. Harwal Publishing Company, Malvern, Pennsylvania, 1992: 209-275
11. Gudjonsson H, Bardhan KD, Hoie O, Kristernsen ES, Schuetz E, Kliebe-Frisch C, Duggan AE. Fligh H pylori eradication rate with one week triple regimens containing ranitidine bismuth citrate (RBC) [abstract] Gut 1997; 41 Suppl 1: 99
12. Spadaccini A, De Fanis C, Sciampa G, Pantaleone U, Di Virgilio M, Pizzicannella G. Lansoprazole or ranitidine bismuth citrate triple therapies for Helicobacter pylori eradication: result of an open randomized study [abstract]. Gut 1997; 41 Suppl 1: 105
13. Catalano F, Catanzaro R, Bentivegna C, Branciforte G, Brogna A, Liberti R, Blasi A. Helicobacter pylori positive duodenal ulcer treated with omeprazole vs ranitidine bismuth citrate triple therapy [abstract]. Gut 1997; 41 Suppl 3: 213
14. Cannizaro O, D'Angelo A, Ederle A, Gerace G, Iaquinto I, Reina C, Riciardello L, Scarpulla G, Spadaccini A, Olivieri A, Tosatto R, R, Roda. E. Assessment of the efficacy and safety of three 7 days eradication regimens containing ranitidine bismuth citrate: results of an Italian study [abstract]. Gut 1997; 41 Suppl 3: 206
15. Susi D. The best treatment for Helicobacter pylori infection among four different 7-day triple therapies [abstract]. Gut 1998; 43 Suppl 2: 80
16. Cestari R, Corti G, Formenti A, Galli F, Gatti M, Marotta F, Milesi F, Paterlini A, Piubello W, Ravelli R, Tonini G, Ubiali P, Valenghi D, Fina P, Olivieri A, Tosatto R. Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with H pylori infection [abstract]. Gut 1998; 43 Suppl 2: 83
17. Ell C, Röllinghoff M, Stolte M, Moser W. Amoxicillin and metronidazole together with either omeprazole or ranitidine in eradication of Helicobacter pylori infection [abstract]. Gut 1998; 43 Suppl 2: 91
18. Ravizza M, Suriani R, Puglisi F, Giacobbe, Gay E, Cappelletti F, Mazzucco D, Dusio R. Helicobacter pylori eradication: RBC plus different antibiotic regimens evaluation in short-term therapy [abstract], Gut 1998; 43 Suppl 2: 85
19. Geccherle A, Montanari R, Marchetta A, Benini M, Fratton A. Ranitidine bismuth citrate based 7-day triple therapy is as effective as a PPI-based short term regimens in eradicating H pylori [abstract]. Digestion 1998; 59 Suppl. 3: 408
20. Hendel L, Pap Á, Porres JC, Wurzer H, Roberts PM. Ranitidine bismuth citrate with clarithromycin and metronidazole twice daily for 7 days eradicates H pylori and heals duodenal ulcers [abstract]. Digestion 1998; 59 Suppl 3: 412
21. Karatapanis S, Keticouglu I, Georgopoulos, Manolatos D, Papamarkos D, Prevedorou D, Arikis V. Ranitidine bismuth citrate plus clarithromycin vs omeprazole plus clarithromycin in the eradication of Hp in patients with DU. A randomized study [abstract]. Digestion 1998; 59 Suppl 3: 414
22. Peyre S, Rizzi R, Bertello OPD. Two antisecretory drugs based one week regimen for eradication of Helicobacter pylor (HP) in duodenal ulcer (DU) patients [abstract]. Digestion 1998; 59 Suppl 3: 426
23. Spinzi GC, Bortoli A, Corbellini A, Colombo E, Lanzi G, Miunoli G. One-week therapy with omeprazole (PPI) or ranitidine bismuth citrate (RBC) and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a preliminary report [abstract]. Digestion 1998; 59 Suppl 3: 432
24. Susi D. Cost and efficacy of 7-day triple therapies for Hp eradication: PPI vs RBC-based treatments [abstract]. Gut 1999; 45 Suppl 5: 106
25. Georgopoulos S, Karatapanis S, Ladas S, Papamarkos D, Vretou N, Artikis V, Mentis A, Raptis S.: Lansoprazole (Lan) vs ranitidine bismuth citrate (RBC) based short-term triple therapies for Helicobacter pylori (H pylori) eradication: a randomised study with 6 month follow-up [abstract]. Gut 1999; 45 Suppl 5: 120
26. Van't Hoff BWM, van der Hulst A, van der Ende A, ten Kate FJW, Houben MHMG, Rauws EAJ, Tytgat GNJ. One week ranitidin bismuth citrate VS omeprazole in combination with clarithromycin and metronidazole for eradication of H pylori infection [abstract]. Gut 1999; 45 Suppl 1: 111
27. Gisbert JP, Carpio D, Marcos S, Gisbert JL, Cabrera MM, Cruzado AI, García Grávalos R, Pajares JM. Pantoprazole vs ranitidine bismuth citrate plus two antibiotics for H pylori eradication [abstract]. Gut 2000, 47 Suppl 3: 126
28. Buzás GyM, Székely E, Illyés Gy, Széles L: One week triple regimens using lansoprazole or ranitidine bismuth citrate for H pylori (Hp) eradication. Gut 1999; 45 Suppl 5: 270
29. Farup PG, Tholfsen J, Wetterhus S, Torp R, Hoie O, Lange OJ. Hp-eradication: ranitidine bismuth citrate vs omeprazole in triple based regimens form one week [abstract]. Gut 2000; 47 Suppl 3: 127
30. Kupcinskas L. Helicobacter pylori (HP) recrudescense is related to efficacy of eradication regimens in high Hp prevalence area [abstract]. Gut 2000; 45 Suppl 3: 104
31. Takáts A, Gero G, Szentmihályi A, Szamosi S, Csiki Z. Efficacy of one-week ranitidine bismuth citrate containing triple therapies for eradication of Helicobacter pylori [abstract]. Gut 2000; 47 Suppl 3: 129
32. Buda A, Dal Bó N, Kusstacher S, Grassi SA, Crestani B, Battaglia G, Pilotto O, Francheschi M, De Bona M, Saladin S, Di Mario M. Different lansoprazole dosages in H pylori eradication therapy: a prospective multicenter, randomised study comparing 30 mg b.i.d. vs 15 mg b.i.d [abstract]. Gut 1997; 41 Suppl 1: 92
33. Jaup BH, Stenquist B, Norrby A. One-week bid therapy for H pylofi: A randomized comparison of three strategies on clinical outcome and side-effects [abstract]. Gut 1997; 41 Suppl 3: 209
34. Gisbert JP, Boixeda D, Aller R, De la Serna C, Sanz; E, Martín de Argila C, Abraira. V, García Plaza A. Bleeding ulcer: H pylori infection prevalence and role of eradication in recurrent haemorrhage [abstract]. Gut 1998; 48 Suppl 2: 85
35. Bazzoli F Zagari RM, Pozzato P, Fossi S, Ricciardiello L, Nicolini G, Alampi G, Roda E. Efficacy of lansoprazole in association with clarithromycin and metronidazole or amoxicillin for H., pylori eradication [abstract]. Digestion 1998; 59 Suppl 3: 400
36. Rinaldi V, Zullo A, Hassan C, Moscatelli R, Lauria V, Attili AF. Management of Helicobacter pylori with consecutive triple therapies [abstract]. Digestion 1998; 59 Suppl 3: 428
37. Colin R, Laurence M, Granjot-Vieillard F.: Helicobacter pylori infection in duodenal ulcer: comparison of two one week triple eradication therapies using lansoprazole or omeprazole [abstract]. Gut 2000; 47 Suppl 3: 126
38. Herszésnyi L, Prónai L, Juhász M, Tulassay Zs.: Evaluation of a short-term and seven days lansoprazole based triple therapy in the treatment of Helicobacter pylori infection [abstract]. Gut 2000; 47 Suppl 3: 127
39. Pilotto A, Dal Bó N, Francheschi M, Bozzola L, Salandion S, Novello R, Leandro G, Meli S, DiMario F, Valerio G. Comparison of three proton pump inhibitors in combination with amoxycillin and metronidazole for one week to cure Helicobacter pylori in the elderly [abstract]. Gut 1998; 48 Suppl 2: 91
40. DiMario F, Dal Bó N, Battaglia G, Benedetti E, Bottono E, Caroli A, Chivoli F, Costan F, De Bastiani R, De Berardinis F, De Pretis G. PantoprazoIe in eradication of peptic ulcer in H pylori positive patients: a multicenter randomised prospective study by GISU (Interdisciplinary Ulcer Study Group) [abstract]. Gut 1999; 45 S3:113
41. Di Mario F, Dal Bó N, Battaglia G, Pilotto A, Franceschi M, Marin R, Del Bianco T, De Bastiani R, Vianello F, Grassi SA, Meggiato T, Del Favero G. Are 6 days of a triple clartihromycin based therapy sufficient to obtain the cure of H pylori infection [abstract]. Gut 1999; 45 Suppl 3: 121
42. Malfertheiner P, Kirchner T, Kist M, Leodoltor A, Peitz, U, Strobel S, The Bagus Study Group. BAGUS: Byk Advances Gastric Ulcer Study - Pantoprazole for H pylori eradication and healing in patients with gastric ulcer [abstract]. Gut 2000; 47 Suppl 1: 100
43. Tulassay Zs. 7-day treatment with esomeprazole-based triple therapy eradicates Hp and heals patients with DU [abstract]. Gut 2000; 47 Suppl 1: 100
44. Bayerdörffer E, Ebert S, Kirsch C, Schneider-Brachert W, Bastlein E, Haferland C, Neumeyer M, Vieth M, Stolte M, Lehn N. Effective one-week triple therapy with esomeprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori in the absence of antimicrobial resistance: a prospective randomised trial [abstract]. Gut 2002; 50 Suppl 2: 101
45. Iacopini F, Crispino P, Consolazio A, Paoluzzl OA, Pica R, Rivera M et al. Once daily 1-week triple therapy with levofloxacin and azithromycin for H pylori eradication [abstract]. Gut 2003; 52 Suppl 6: 204
46. Nista C, Candelli M, Cazzato IA, Fini L, Gabrielli M, Zocco MA et al. Moxifloxacin-based treatments: a new chance for H pylori eradication [abstract]. Gut 2003; 52 Suppl 6: 204
47. Fini L, Nista EC, Candelli M, Cazzato IA, Franceschi F, Santoro M et al. First-line treatment for Helicobacter pylori eradication: levofloxacin/ azitrhomycin-based strategies [abstract]. Helicobacter 2004; 9: 571
48. Zullo A, Scaccianoce G, Hassa C, Panarese A, Piglionica D, Morini S. Helicobacter pylori eradication with 7-day triple therapy, 10-day regimens, and sequential therapy [abstract]. Gut 2004; 3 Suppl 6: 120
49. Stack WA, Knifton A, Jenkins D, Cockayne A, Jolly M, Bell N, Humphries T, Hawkey CJ, Atherton JC. Rabeprazole is effective and safe when used in combination with antibiotics for the eradication of Helicobacter pylori [abstract]. Gut 1997; 47 Suppl 3: 205
50. Karatapnis S, Georgopoulos S, Papakonstantinou L, Papamarkos D, Mentis A, Artikis V. Rabeprazole 7-days vs rabeprazole 10-days triple therapy in the eradication of H pylori infection. A randomized study. [abstract] Gut 2000; 47 Suppl 1: 107
51. Pilotto A, Di Mario F, Francheschi M, Dal Bó N, Bozzola L, Rassu M, Novello R. Efficacy of one-week triple therapies with low-dose rabeprazole and clarithromycin plus standard dose amoxicillin or tinidazole for the cure of H pylori infection in elderly patients [abstract]. Gut 2001; 49 Suppl 2: 95
52. Moussa A, Ingegnoli A, Seghini P, Aragona G, Cavestro GM, Dal Bó N, Pilotto A, Leandro G, Rugge M, Di Mario F. One-week H pylori eradication therapy with rabeprazole 20 mg bid vs 10 mg bid [abstract]. Gut 2001; 49 Suppl 3: 98
53. Hawkey CJ, Atherton JC, Treichel HC, Ravic C, Thjodeifsson B. Rabeprazole vs omeprazole in 7-day triple therapy H pylori eradication regimens for peptic ulcer [abstract]. Gut 2001; 49 Suppl 3: 96
54. Di Caro S, Zocco MA, Cremonini F, Bartolozzi F, Armuzzi A, Carloni E, Nista EC, Candelli M, Lupascu A, Santarelli L, Cammarotta G, Gabrielli M, Gasbarrini G, Gasbarrini A. Efficacy of 5,7 and 10 days of levofloxacin-based dual therapy for H pylori eradication [abstract]. Gut 2001; 49 Suppl 2: 105
55. Cammarota G, Cianci R, Vero V, Urgesi R, Gasbarini G. Efficacy of rabeprazole/levofloxacin-based triple therapy for Helicobacter pylori eradication [abstract]. Gut 2002; 50 Suppl 2: 95
56. Calvet X, Helicobacter pylori working group of the Asociatión Espanola de Gastroenterologia. (AEG): Randomised controlled trial comparing 7 vs 10 days of triple therapy using rabeprazole, clarithromycin and amoxicillin for Helicobacter pylofi (Hp) eradication. Preliminary results [abstract]. Helicobacter 2004; 9: 572
57. Cavestro GM, Dal Bó N, Francheschi M, Maino M, Mantovanio N, Campi L, Pilotto A, Lenadro G, Rugge M, DiMario F.: Comparison of different dosages of PPI in one-week Helicobacter pylori eradication therapy [abstract]. Gut 2002; 50 Suppl 2: 92
58. Ruszniewski P, Lamouliatte H, Fléjou JF, Mégraud F, Slama A. Evaluation of short-term ranitidine vs omeprazole triple therapy regimens for eradication of Helicobacter pylori (Hp) in duodenal ulcer (DU patients (pts) [abstract]. Gut 1997; 41 Suppl 1: 94
59. Popovic N, Bujacic M, Glisic M, Popovic P, Milosavljevic T, Popovic N, Matejic O. Comparison of two triple therapies (ranitidine plus amoxicilline plus tinidazol vs omeprazole plus amoxicillin plus tinidazol) in patients with Helicobacter pylori positive duodenal ulcer [abstract]. Gut 1997; 41 Suppl 1: 102
60. Jonaitis L, Kupcinskas L, Kiudelis G, Ciozaukas A. Insufficient results of eradication in high Helicobacter pylori prevalence region [abstract]. Gut 1999; 45 Suppl 3: 117
61. Pieramico O, Zanetti MV, Innerhofer M. Outcome of omeprazole-based dual and triple therapy for Helicobacter pylori eradication: do gastroduodenal diseases and age play a role? [abstract]. Gut 1997; 41 Suppl 1: 91
62. Marusic M, Katicic K Presecki V, Prskalo M, Ticak M, Sabaric B, Kalenic S, Papa,B, Colic-Cvrlje V, Namuvoski-Mihalic S, Plecko V. Eradication of H pylori infection in hospitalized and non-hopitalized patients[abstract]. Gut 1997; 41 Suppl 3: 166
63. Tchernev K, Michailov G, Kandilarov N, Hubaveshka M, Boneva I. Comparison of two different therapeutic regimens for eradication of Helicobacter pylori in patients with "penetrant" duodenal ulcers [abstract]. Gut 1997; 41 Suppl 3: 195
64. Witteman EM, Hazenberg BP, Haeck PWE, Tan TG, Kock PHT, Dekkers CPM, Steen H, Jansen JBMJ. Comparison of pantoprazole-based dual and triple therapies for H pylori eradication: effect on symptoms in non-ulcer dyspepsia patients [abstract]. Gut 1997; 41 Suppl. 3: 199
65. Di Mario F, GISU Interdisciplinary Ulcer Study Group: A one week triple therapy vs two week dual therapy for eradication and healing of Helicobacter pylori positive duodenal ulcers (DU): results from a randomised double clinical trial [abstract]. Gut 1997; 41 Suppl3: 212
66. Calvet X, Cuibells MJ, López Lorente T, Baré M, Galvez E, Molina E, Esteve MR. Clarithromycin based dual and triple therapies for treatment of Helicobacter pylori infection in primary care: a multicenter comparative, randomized study [abstract]. Gut 1998; 43 Suppl 2: 82
67. Bazzoli F, Bianchi Porro G, Fiocca R, Gasbarrini G, Roda E, Zagari RM. Eradication of Hp with omeprazole plus amoxicillin or amoxicillin and clarithromycin for 1 or 2 weeks in patients with duodenal ulcer [abstract]. Gut 1999; 45 Suppl 5: 6
68. De Francesco V, Sgarro C, Cela E, Stoppino V, Minenna F. Helicobacter pylori eradication rates in non-ulcer dyspepsia (NUD) and duodenal ulcer (DU) patients [abstract]. Gut 2001; 49 Suppl 2: 94
69. Bago J, Belosic Jalle Z, Strinic D, Bilic A. Antimicrobial resistance of H pylori to the outcome of dual vs triple lansoprazole based therapy for eradication [abstract]. Gut 2001; 49 Suppl 3: 98
70. Arkilla P, Farkkilaz M, Kosunen T, Nuutinen H, Sipponen P, Seppala. K. Safety of peptic ulcer treatment with only Helicobacter pylori eradication without the following proton pump inhibitor treatment [abstract]. Gut 2000; 47 Suppl 3: 135
71. Mégraud F, Pichavant R, Palegry D, Ferench PC, Roberts PM, Williamson R. Ranitidine bismuth citrate (RBC) co-prescribed with clarithromycin is more effective in the eradication of Helicobacter pylori than omeprazole with clarithromycin [abstract]. Gut 1997; 41 Suppl 1: 912
72. Cardelli A, Cordiano C, Giglio A, Lami F, Pilotto A, Pozzat P, Scarpulla G, Spadaccini A, Susi D, Olivieri A, Tosatto R, Roda E. A new dual 7-day therapy is effective in eradicating Helicobacter pylori in duodenal ulcer patients [abstract]. Gut 1997; 41 Suppl 1: 96
73. Huelin Benitez J, Jimenez Perez M, Sánchez Galdón S, Durán Campos A, Cárdenas Mártinez A, Espana Contreras P, de la Cruz J, Lozano JM, Maldonado G. Short course treatment to eradicate H pylori in 246 patients with peptic ulcer disease [abstract]. Gut 1997; 41 Suppl 1: 105
74. Mantzaris GJ, Tzathas H, Petraki K, Spiliades Ch, Archavlis E, Amberiadis P, Kourtessas D, Christoforidis P, Trianafyllou G. A prospective study comparing various anti-H pylori treatment regimens for patients with peptic ulcer disease [abstract]. Gut 1999; 45 Suppl 5:192
75. Kashin S, Politov I, Agamov A, Levina A, Gruzdeva T, Nadezhin A, Lupov V, Shchebakov P. Evaluation of different 7-day therapies for H pylori eradication in patients with peptic ulcer disease. A 6 year experience [abstract]. Gut 2001; 49 Suppl 2: 94
76. Iakovenko EP, Grigoriev P, Yakovenko AV, Bikbavova R, Anashkin V, Anaeva T, Aldiyarova. M, Soluyanova I. Bismuth based regimes should be first line therapy for Helicobacter pylori eradication [abstract]. Gut 2002; 51 Suppl 2: 92
77. Frevel M, Daake H, Janisch HD, Kelner HU, Krezdorn H, Tanneberger D, Wack R, Gatz G. Pantoprazole plus clarithromycin and metronidazole versus pantoprazole plus clarithromycin and amoxycillin for therapy of H pylori infection [abstract]. Gut 1997; 41 Suppl 1: 103
78. Michopoulos S, Bouzakis H, Balta A, Sotiropoulou M, Tasibouris P, Papaspyrou I., Vougadiotis I, Markaki S. Randomized study comparing three different triple regimemns containing clarithromycin for H pylofi (HP) eradication in patients with duodenal ulcer (DU) [abstract]. Gut 1997; 41 Suppl 3: 209
79. Passigato N, Biti L, Marxconi I, Benedetti S, Negri A, Dotto E. Comparison of three alternative strategies for Helicobacter pylori eradication in patients with chronic gastritis [abstract]. Gut 1997; 41 Suppl 3: 210
80. Houben MHMG, Hensen EF, van'Hoff BWM, van der Hulst RWM, Rauws EAJ, van der Ende A, ten Kate FJW, Tytgat GNJ. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole resistant or sensitive Helicobacter pylofi strains [abstract]. Gut 1998; 43 Suppl 2: 87
81. Perri F, Festa V, Clemente R, Quitamado M, Andriulli A. Failure of standard triple therapies for H pylori eradication in dyspeptic patients [abstract]. Gut 1999; 45 Suppl 3: 113
82. Pieramico O, Zanetti MV. Role of metronidazole and clarithromycin resistance on the outcome of omeprazole-based triple therapies for H pylori eradication [abstract]. Gut 1999; 45 Suppl 3: 116
83. Idda M, Piana A, Carta M, Are BM, Mura I, Dore MP, Realdi G. Pre-treatment susceptibility vs blinded treatment: a randomized trial of antimicrobial therapy for H pylori infection [abstract]. Gut 2000; 47 Suppl 1: 101
84. Paoluzzi P, Iacopini F, Consolazio A, Paoluzi OA, Rossi P, Rivera M, Crispino P, Pica R, Nardi F, Paoluzi P. Two week PPI-based triple therapy with amoxycillin and clarithromycin has a higher efficacy in Helicobacter pylori eradication [abstract]. Gut 2001; 49 Suppl 3: 254
85. Katicic M, Presecki V, Marusic M, Prskalo M, Ticak M, Sabaric B, Dominis M, Kalenic S, Dzebro S, Colic-Cvrlje V, Papa B, Naumovski-Mihalic S, Plecko V. Eradication of H.pylori infection with two triple-therapy regimens of 7,10 and 14 days [abstract]. Gut 1997; 41 Suppl 1: 100
86. Unge P. Antimicrobial treatment of H pylori infection - a pooled efficacy analysis of eradication therapies. Eur J Surg Suppl 1998; 16-26
87. Gisbert JP, Gonzalez L, Calvet X, Garcia N, Lopez T, Roque M, Gabriel R, Pajares JM. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000; 14: 1319-1328
88. Vergara M, Vallve M, Gisbert JP, Calvet X. Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2003; 18: 647-654
89. Gisbert JP, Khorrami S, Calvet X, Pajares JM. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2004; 16: 89-99
90. Gisbert JP, Khorrami S, Calvet X, Pajares JM. Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication. Aliment Pharmacol Ther 2003; 17: 517-7564
91. Gisbert JP, Pajares JM. Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis. Dig Liver Dis 2004; 6: 253-259
92. De Francesco V, Zullo A, Hassan C, Della Valle N, Pietrini L, Minenna MF, Winn S, Monno R, Stoppino V, Morini S, Panella C, Ierardi E. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randon-dsed study. Dig Liver Dis 2004; 36: 322-326
93. Gisbert JP, Gonzalez L, Calvet X. Systematic review and metaanalysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter 2005; 10: 157-171
94. Graham DY, Hammoud F, El-Zimaity HM, Kim JG, Osato MS, El-Serag HB. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther 2003; 17: 1229-1236
95. Gisbert JP, Khorrami S, Calvet X, Gabriel R, Carballo F, Pajares JM. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists - their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther 2003; 18: 757-766
96. Gene E, Calvet X, Azagra R, Gisbert JP. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 2003; 17:1137-1143
97. Broutet N, Tchamgoue S, Pereira E, Lamouliatbe H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003, 17: 99-109
98. Bytzer P, O'Morain C. Treatment of Helicobacter pylori. Helicobacter 2005; 10 Suppl 1: 40-46
99. Calvet X. Helicobacter pylari infection: treatment options. Digestion 2006; 73 Suppl 1: 119-128